Moreover, in a model of melanoma, myeloid cells was shown to produce IL-1β (37), which subsequently activated endothelial cells to produce VEGF and other proangiogenic factors, modulating the inflammatory microenvironment of the tumor, allowing for enhanced angiogenesis and tumor progression. Here, IL1B is linked to neoplasm.